• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

CD24-targeting drug delivery system enhanced effect of cisplatin-resistant ovarian cancer cells

Research Project

Project/Area Number 25462621
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Obstetrics and gynecology
Research InstitutionOsaka Medical College

Principal Investigator

TERAI YOSHITO  大阪医科大学, 医学部, 准教授 (90278531)

Co-Investigator(Kenkyū-buntansha) Ohmichi Masahide  大阪医科大学, 医学部, 教授 (10283764)
Kanemura Masanori  大阪医科大学, 医学部, 講師 (40298782)
Tanabe Akiko  大阪医科大学, 医学部, 講師 (70454543)
Yamashita Yoshiki  大阪医科大学, 医学部, 講師 (50268207)
Hayashi Masami  大阪医科大学, 医学部, 講師 (00551748)
Yoo Saha  大阪医科大学, 医学部, 助教 (80625674)
Tsunetoh Satoshi  大阪医科大学, 医学部, 講師 (70388255)
Tanaka Yoshimichi  大阪医科大学, 医学部, 助教 (10625502)
Project Period (FY) 2013-04-01 – 2016-03-31
Project Status Completed (Fiscal Year 2015)
Budget Amount *help
¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2015: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2014: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2013: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Keywords卵巣癌 / EMT / CD24 / ドラッグデリバリー / 腹膜播種転移 / 薬剤耐性 / 高分子ミセル / 卵巣がん / drug delivery system / E-cadherin / Snail / colony formation
Outline of Final Research Achievements

We developed a cisplatin encapsulated polymer micelle targeting (CDDP-CD24-LIPO) of drug delivery system for cisplatin-resistant ovarian cancer cells. We examined the peritoneal dissemination model of cisplatin-resistant ovarian cancer cell lines (Caov3). The cisplatin concentration of disseminated cancer cells with CDDP-CD24-LIPO group was significantly higher than that with CDDP group (p <0.05), the cisplatin concentration in the kidney was significantly lower. Overall survival with CDDP-CD24-LIPO group (71.2 ± 28.3 days) showed a significantly prolonged compared with CDDP group (47.8 ± 7.4 days) (p <0.05). CDDP-CD24-LIPO has enhanced therapeutic effect in refractory ovarian cancer.

Report

(3 results)
  • 2015 Annual Research Report   Final Research Report ( PDF )
  • 2013 Research-status Report
  • Research Products

    (2 results)

All 2015 2014

All Presentation (2 results)

  • [Presentation] シスプラチン内包CD24高分子ミセルを用いた難治性卵巣癌モデルへの治療応用2015

    • Author(s)
      芦原敬允、寺井義人、古形祐平、藤田和也、小野賀大、藤原聡枝、田中良道、田中智人、佐々木浩、恒遠啓示、金村昌徳、田辺晃子、大道正英
    • Organizer
      第14回日本婦人科がん分子標的研究会
    • Place of Presentation
      松本市
    • Year and Date
      2015-07-18
    • Related Report
      2015 Annual Research Report
  • [Presentation] 難治性卵巣癌の浸潤・転移に関わる分子をターゲットとした新規治療法の開発2014

    • Author(s)
      寺井義人
    • Organizer
      第66回日本産科婦人科学会
    • Place of Presentation
      東京国際フォーラム
    • Related Report
      2013 Research-status Report

URL: 

Published: 2014-07-25   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi